Insight · ARRS
Insight — deploying ARRS underspend before year-end.
Why ARRS underspend happens.
PCN underspend almost always traces back to four causes. First, solo pharmacist recruitment that takes six to nine months and routinely fails twice before a successful placement. Second, supervision gaps that mean an ARRS role is technically filled but cannot be evidenced for audit, so the spend is at risk. Third, sickness, maternity and turnover events that leave a role empty for months at a time. Fourth, technician capacity that goes unused because PCNs default to recruiting pharmacists first and run out of management bandwidth before they get to technicians. The combined effect is that even well-organised PCNs commonly land between 70 and 85 per cent of allocation by January, with a meaningful Q4 gap to close.
What's at stake
What underspend costs your PCN.
- Forfeited reimbursement at financial year-end — funding that does not roll forward
- Lost patient impact from the structured reviews, monitoring and reconciliation the role would have delivered
- ICB scrutiny on subsequent allocations where deployment history is weak
- GP and Practice Manager frustration with the perception that pharmacist roles 'don't get filled'
- Lower QOF and IIF achievement in domains where pharmacist input drives the numbers
The fast route
Mobilising in weeks, not months.
A managed provider exists precisely for this scenario. BCS can scope, cost and mobilise an ARRS-compliant pharmacist or technician role for a PCN in four to six weeks, with remote prescribing capacity available even faster from our Halifax or Chiswick hubs. The role lands fully supervised, governance-documented and outcome-tracked from day one, which means the spend is defensible at audit and the patient impact is visible from the first month.
- Scoping call within 48 hours of enquiry
- Written proposal — role, supervisor, SLA, mobilisation date — within one week
- ARRS-compliant role design, indemnity and DPIA included
- Outcomes report from month one for ICB and PCN governance
- Scales up or down with your remaining allocation
What a 90-day Q4 deployment looks like.
A typical Q4 mobilisation runs in three phases. Weeks one to three: scoping, contracting, IT and clinical system access, supervisor allocation and induction. Weeks four to six: pharmacist or technician on-site or remote, beginning structured review work against the PCN's chosen cohort — usually polypharmacy in the over-75s, care home residents, or discharge reconciliation backlogs. Weeks seven to twelve: full delivery cadence with weekly clinical supervision, monthly outcomes report, and ARRS evidence pack ready for ICB submission. By the end of the financial year a PCN that started Q4 at 75 per cent allocation can credibly land above 95 per cent with documented outcomes attached.
Where Q4 capacity lands best
High-impact deployment options.
- Polypharmacy reviews for over-75s on 10+ regular medicines
- Care home structured medication reviews
- Hospital discharge medicines reconciliation backlogs
- High-risk drug monitoring catch-up (DMARDs, lithium, amiodarone, anticoagulants)
- Repeat prescribing optimisation and cost-saving programmes
- QOF cardiovascular, diabetes and respiratory indicator improvement
Getting the ICB and Clinical Directors aligned.
Q4 mobilisation works best when the ICB Medicines Optimisation team and the PCN Clinical Director are aligned on what the spend is for. The strongest deployments we've supported all share three traits: a clear written cohort definition, a named PCN clinical lead who signs off the work, and an outcomes report template agreed at the start. With those three in place, the ICB sees the spend as a planned, governed deployment rather than a last-minute drawdown — which protects future allocation conversations.
FAQs — ARRS underspend.
How late in the year can BCS still mobilise?+
Realistically, BCS can mobilise meaningful capacity into a PCN with at least six to eight weeks remaining in the financial year. Even shorter windows can be useful for remote prescribing and technician-led catch-up work.
Will the spend be ARRS-compliant?+
Yes. Every BCS role is designed against the Network Contract DES, with supervision and indemnity evidenced for audit from day one.
What if our underspend is small?+
BCS can scope sub-PCN packages, including short technician sprints and remote-only pharmacist sessions, so smaller underspend is still deployable.
Does this commit us beyond year-end?+
No. Mobilisation contracts are scoped to the funding available. Continuation into the next year is a separate decision based on results.
Related BCS work.
Talk to BCS.
If you'd like to walk through what this would look like for your PCN specifically, talk to our Service Development team. We'll cost a plan against your remaining ARRS allocation and your existing pharmacy workforce, and have a written proposal back within a week.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.